AT504557T
Aspirin-triggered lipid mediators
Abstract
This record has no abstract on file.
Term
Term ended
Expired 16 February 2021, 5.6 years ago.
- Priority
- Filed
- Granted
- Expired
- Today
54 members in 12 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 18307800 | United States of America | P | |
| 23881400 | United States of America | P |
Members54
| Document | Office | Kind | |
|---|---|---|---|
| CA2400462A1 | Canada | A1 | |
| WO0160778A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU3846801A | Australia | A | |
| US2002055538A1 | United States of America | A1 | |
| WO0160778A9 | World Intellectual Property Organization (WIPO) | A9 | |
| WO0160778A3 | World Intellectual Property Organization (WIPO) | A3 | |
| EP1296923A2 | European Patent Office (EPO) | A2 | |
| IL151299D0 | Israel | D0 | |
| JP2003525880A | Japan | A | |
| US6670396B2 | United States of America | B2 | |
| CN1469858A | China | A | |
| US2004059144A1 | United States of America | A1 | |
| CN1202068C | China | C | |
| MXPA02007915A | Mexico | A | |
| CN1680259A | China | A | |
| US7053230B2 | United States of America | B2 | |
| AU2001238468B2 | Australia | B2 | |
| AU2006225252A1 | Australia | A1 | |
| AU2006225252A2 | Australia | A2 | |
| EP1296923B1 | European Patent Office (EPO) | B1 | |
| AT344226T | Austria | T | |
| ATE344226T1 | Austria | T1 | |
| DE60124256D1 | Germany | D1 | |
| US2007049639A1 | United States of America | A1 | |
| EP1762557A2 | European Patent Office (EPO) | A2 | |
| CN1951899A | China | A | |
| DE60124256T2 | Germany | T2 | |
| EP1762557A3 | European Patent Office (EPO) | A3 | |
| CN100357244C | China | C | |
| HK1105948A1 | Hong Kong, China | A1 | |
| AU2006225252B2 | Australia | B2 | |
| US2009149538A1 | United States of America | A1 | |
| AU2009202071A1 | Australia | A1 | |
| US7709669B2 | United States of America | B2 | |
| US7737178B2 | United States of America | B2 | |
| US2010216882A1 | United States of America | A1 | |
| JP2010248213A | Japan | A | |
| EP1762557B1 | European Patent Office (EPO) | B1 | |
| CN102010324A | China | A | |
| AT504557TThis record | Austria | T | |
| ATE504557T1 | Austria | T1 | |
| DE60144401D1 | Germany | D1 | |
| AU2009202071B2 | Australia | B2 | |
| CA2400462C | Canada | C | |
| CN1951899B | China | B | |
| EP1296923B3 | European Patent Office (EPO) | B3 | |
| JP4932116B2 | Japan | B2 | |
| DE60124256T3 | Germany | T3 | |
| US8349896B2 | United States of America | B2 | |
| CN102010324B | China | B | |
| JP2015007046A | Japan | A | |
| JP2016006057A | Japan | A | |
| JP5973503B2 | Japan | B2 | |
| JP2019108348A | Japan | A |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Ceased as to paragraph 5 lit. 3 law introducing patent treatiesCeasedRER | RER |
Numbers
- Application
- 6022386
Titles2
- German
- ASPIRIN-AUSGELÖSTE LIPIDMEDIATOREN
- English
- ASPIRIN-RELATED LIPID MEDIATORS
Classification
- CPC, 27
- C07C59/58
- A61P1/00
- C07B2200/07
- A61P1/04
- C07C59/42
- A61P7/02
- C07C69/732
- A61P9/00
- C12P7/6427
- A61P9/10
- C12P7/6436
- A61P9/14
- C12P7/6472
- A61P11/00
- Y02P20/55
- A61P11/06
- A61P17/00
- A61P17/02
- A61P17/04
- A61P17/06
- A61P17/08
- A61P19/00
- A61P19/02
- A61P27/02
- A61P29/00
- A61P37/08
- A61P43/00
- IPC, 17
- A61K31 616
- C07C59 58
- A61K31 202
- A61P9 10
- A61P9 14
- A61P11 00
- A61P11 06
- A61P17 04
- A61P17 06
- A61P17 08
- A61P19 02
- A61P27 02
- A61P29 00
- A61P37 08
- C07C59 42
- C07C69 732
- C07C233 09